Myelogenous Leukemia, Acute
1 competing product in clinical development for Myelogenous Leukemia, Acute.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Bisantrene + Fludarabine + Clofarabine | Race Oncology | Phase 2 | UNKNOWN | 44 |